tiprankstipranks
Seelos Therapeutics (DE:NXEN)
FRANKFURT:NXEN

Seelos Therapeutics (NXEN) Ownership - Who Owns Seelos Therapeutics?

0 Followers

Seelos Therapeutics (NXEN) Ownership Overview

0.00%0.00%16.05%83.95%
16.05% Other Institutional Investors
83.95% Public Companies and
Individual Investors
The ownership structure of Seelos Therapeutics (DE:NXEN) stock is a mix of institutional, retail and individual investors. Approximately 16.05% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 83.95% is owned by Public Companies and Individual Investors.
The ownership structure of Seelos Therapeutics (DE:NXEN) stock is a mix of institutional, retail and individual investors. Approximately 16.05% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 83.95% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Currently, No Data Available
Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2023Bought$133321

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
155,396Insider22,532
55,735Insider8,082
32,352Insider4,691
15,433Insider2,238
20,000Insider2,900
26,500Insider3,843
115,891Insider16,804
7,831,324Insider1,135,542
14,866Institution2,156
4,991,013Institution723,697

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
24,583Institution3,565
1,134,597Institution164,517
73,139Institution10,605
4,815,935Institution698,311
73,332Institution10,633
39,148Institution5,676
-10,804Institution-1,567

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Seelos Therapeutics (DE:NXEN)?
According to the latest TipRanks data, approximately 16.05% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 83.95% is held by retail investors.
    What percentage of Seelos Therapeutics (DE:NXEN) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 16.05% of Seelos Therapeutics (DE:NXEN) stock is held by institutional investors.
      What percentage of Seelos Therapeutics (DE:NXEN) stock is held by retail investors?
      According to the latest TipRanks data, approximately 83.95% of Seelos Therapeutics (DE:NXEN) stock is held by retail investors.
        Who owns the most shares of Seelos Therapeutics (DE:NXEN)?
        Richard Pascoe owns the most shares of Seelos Therapeutics (DE:NXEN).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis